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Abstract 
Pulmonary rehabilitation (PR) is a guideline-recommended multifaceted intervention that 
improves the physical and psychological well-being of people with chronic respiratory 
diseases (CRDs), though most of the evidence derives from trials in high resource settings.  
In low- and middle-income countries PR services are under-provided. We aimed to review 
the effectiveness, components and mode of delivery of PR in low-resource settings. 
Following Cochrane methodology, we systematically searched (1990 to October 2018; pre-
publication update March 2020) MEDLINE, EMBASE, CABI, AMED, PUBMED and CENTRAL for 
controlled clinical trials of adults with CRD (including but not restricted to chronic 
obstructive pulmonary disease) comparing PR with usual care in low-resource settings. After 
duplicate selection, we extracted data on exercise tolerance, health-related quality-of-life 
(HRQoL), breathlessness; included components; and mode of delivery. We used Cochrane 
Risk-of-Bias (RoB) to assess study quality, and synthesised data narratively. From 8912 hits 
we included 13 studies; 11 were at high RoB; 2 at moderate RoB. PR improved functional 
exercise capacity in 10 studies, HRQoL in 12, and breathlessness in 9 studies. One of the two 
studies at moderate RoB showed no benefit. All programmes included exercise training; 
most provided education, chest physiotherapy, breathing exercises.  Low cost services 
adapted to the setting, used limited equipment, and typically combined outpatient/centre 
delivery with a home/community-based service. Multicomponent PR programmes can be 
delivered in low resource settings, employing a range of modes of delivery.  There is a need 
for a high-quality trial to confirm the positive findings of these high/moderate RoB studies.    
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Introduction 
The epidemiological transition from communicable to non-communicable disease (NCDs) 
imposes a ‘double burden’ on low- and middle-income countries (LMICs)1 which continue to 
combat infectious diseases but are typically not yet ready to manage NCDs including Chronic 
Respiratory Diseases (CRDs).2 CRDs are common3,4 and disabling5-7 imposing a substantial 
burden in LMICs.  Poor awareness, and insufficient resources8-10 in terms of infrastructure 
for diagnosis, availability of essential drugs, skilled health professionals, and overall health 
care priorities5  limit management options.11 
 
Pulmonary rehabilitation (PR) is an effective component of CRD care.12 PR is a 
comprehensive, multidisciplinary, individually-tailored intervention designed to overcome 
the deconditioning induced by CRDs.13 The components of PR include, but are not limited to 
exercise programmes, chest physiotherapy, education, and supporting self-management 
and lifestyle change, after optimising the recommended pharmacotherapy.13-15 PR cost-
effectively reduces symptoms, morbidity, hospital admission (and readmission), duration of 
hospital stay, emergency medical help and improves functional exercise capacity, and health 
related quality of life (HRQoL).16-20  
 
However, most of the evidence is generated from high-income countries (HICs) and is 
disease specific21-24 (most commonly chronic obstructive pulmonary disease (COPD)), 
whereas respiratory disease is often much less differentiated in LMICs.  In addition, PR 
services as developed in HICs, may not be deliverable in the same format in LMICs25,26 with 
substantial differences in resources, awareness, culture, healthcare configuration and 
profile of diseases,27,28 that may affect overall management strategy. The potential gains to 
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individuals and healthcare economies, however, are large given the burden of disease in 
LMICs.29,30 
 
Despite well-established effectiveness,19,23 PR services are often unavailable even in high-
income countries31-33 and uptake (by clinicians and patients) is poor particularly in LMICs 
and especially in rural communities.34 A strategy is needed to elaborate PR programmes 
that are deliverable and effective in LMICs. We therefore aimed to systematically search the 
literature to: 1) assess the impact of PR on HRQoL and exercise capacity, when delivered in 
low-resource settings for people with CRD, 2) identify the components used in effective 
interventions and 3) describe the models of care deliverable in the low-resource settings. 
 
Results 
Study selection 
Our systematic review identified 8912 records. We also found an additional 82 records from 
forward citation. Following the removal of duplicates, 7437 titles and abstracts were 
screened (Figure 1). Fifty-six articles were reviewed in full text, with 43 articles excluded. 
Thirteen articles met the review criteria and were included.35-47 No additional papers were 
identified in the pre-publication update.   Total recruitment for the study was 661 
individuals with CRD.   Attrition was reported in nine studies; 96 (20%) of 479 subjects 
dropped out. 
 
Study participants 
Study participants were COPD patients35,37-47 of varying degree of severity in all the trials 
except one which recruited people with Pulmonary Impairment After TB (PIAT).36 Total 
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number of enrolled participants were 661 of which COPD and PIAT were 83% and 17% 
respectively.  
 
Geographical area 
The trials were conducted in Turkey (n=4),35,39,40,43 Brazil (n=3),37,41,46 India (n=2),38,47 Egypt 
(n=1),42 Iran (n=1), 44South Africa (n=1),36 and  Venezuela (n=1).45  
 
Study settings 
Five studies were conducted at hospital outpatient departments37-39,43,45 with or without 
continuation of exercise at home, seven were home-based35,36,40,42,44,46,47 training with or 
without telephonic/face-to-face monitoring or supervision, and one trial was conducted in a 
community centre.41 Wherever the PR was delivered, all baseline and follow-up data were 
collected in a hospital/centre setting. 
 
Risk of Bias assessment  
Overall RoB is shown in the first column of Table 1 and detailed in supplementary results 1.  
Almost all studies were at overall high RoB, with only two studies,36,39 which concealed 
randomisation and took steps to avoid other biases, were at moderate RoB.  Due to the 
nature of intervention, blinding of the patients or the personnel delivering the PR was not 
possible, but only one study explicitly stated that outcome assessment was blind to 
allocation.36 Attrition was a problem or was not clear in all but three studies.39,41,46 None of 
the studies had a published protocol, so selective reporting could not be assessed.  
 
Effectiveness of intervention (Objective 1) 
 
 
 
7
Although 6-MWT, SGRQ and mMRC were widely used to assess functional exercise capacity, 
HRQoL and breathlessness, only six of the trials presented between group 
comparisons.36,39,40,42,44,46 The other seven provided within group differences.35,37,38,41,43,45,47 
In addition, heterogeneity in terms of mode of intervention, duration, setting, comparator 
and baseline measurements, confirmed our decision that meta-analysis was not 
appropriate.  
 
We therefore undertook a narrative synthesis and illustrated functional exercise capacity, 
HRQoL and breathless in a Harvest plot (Figure 2).  Our interpretation of the study findings 
and the structured process determining the decisions that underpinned the Harvest plot are 
described in Column 5 of Table 1.   
 
Changes in functional exercise capacity were measured in 11 studies.35-43,46,47 Significant 
positive changes were found in 10 studies;35,37-43,46,47 the exception being one of the two 
studies at moderate RoB.53 HRQoL was measured in 12 studies;35,37-47 all showing positive 
changes. Breathlessness was measured in 11 studies35-39,41-43,45-47 of which nine studies35,37-
39,41-43,45,47 showed significant positive changes and two studies (one at moderate RoB)36,46 
showed no changes after intervention. None of the studies reported negative effects after 
the intervention.  
 
Components of the intervention (Objective 2)  
All interventions included exercise and non-exercise components (as per inclusion criteria), 
though the approach, content, method of delivery and duration varied. The components are 
described in Table 1, and their presence indicated in a matrix in Table 2. 
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Endurance training was included in all 13 studies. Other common exercises were upper limb 
exercise,35-37,39,45,46 and strength training in seven studies,37-40,42,43,46 and stretching exercises 
in four studies.39,42,43,45 Although not described in detail, the other common component was 
breathing exercises included in eight studies.35,36,38,42-45,47 Along with the exercise, patient 
education was provided in 10 studies,35,36,38-44,46 and skills (such as inhaler technique & 
airway clearance) were included in seven studies.35,36,39,40,42,43,47 Other components in a 
minority of studies were social support,38 optimisation of pharmacotherapy,35,37 
nutrition,40,42-44 coping strategies,35,38,40,43,47 psychological intervention,35,40,43,46 self-
management,42 and physical activity interventions.43,44,46 Surprisingly, smoking cessation 
support was reported in only two studies.35,44  
 
Models of care (Objective 3)  
We identified three models of PR service in our included studies according to the settings in 
which they were delivered (see Table 3).   Five were based in hospital or rehabilitation 
centres,37-39,43,45 and one was based in a community health centre.41 Only one was delivered 
completely at home35 while most home-based programmes36,40,42,44,46,47 provided initial 
training in the hospital or centre and maintained telephone40,44,46 or face-to-face 
supervision.42,47 The programmes typically lasted 8 weeks (range 4 to 12), with supervised 
sessions lasting between 30 and 120 minutes provided 2 or 3 times per week.   Home-based 
programmes promoted more frequent exercise sessions often supported by telephone or 
face-to-face contacts.  Physiotherapists provided the sessions in 6 studies,36,38-41,43 with 
nurses involved in 4 studies.35,40,42,44  Adherence to the PR course was poorly reported with 
no details provided about reasons for non-completion. 
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Inexpensive instruments were often used in the studies which ensured the wide availability 
and acceptability to the consumers. Lower-limb endurance exercise was conducted by 
walking as opposed to expensive stationary-bicycle with upper limb resistance/strength 
training was conducted using home-made weights such as water bottles. Breathing 
exercises were done with similar devices that are used in higher resource setting (e.g. 
incentive spirometers, tri-flow). 
 
Discussion 
In summary, our systematic review identified and selected 13 heterogeneous studies from 
seven different countries with a total study population of 661 patients. Overall, PR was 
reported as being effective in terms of improving functional exercise capacity, HRQoL and 
breathlessness, though risk of bias was high in eleven studies. Of the two at moderate RoB, 
one showed no benefit in any of the outcomes reported.36 The exercise programmes 
typically included endurance, interval, upper limb, and resistance/strength training.   The 
commonest additional components were education to improve knowledge and skill 
acquisition (e.g. inhaler technique) and strategies for coping with breathlessness.  Smoking 
cessation was provided in only two studies. Most PR services were provided in hospital 
settings or home-based, with some describing adaptations to locally acceptable and 
deliverable approaches. 
 
The strength of this systematic review is its broad literature search constructed with the 
help of a senior librarian and informed by Cochrane’s standard search terms for COPD and 
LMICs. Nevertheless, we may have missed important studies of PR conducted in low 
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resource settings.  Although we did not specifically search for papers in other languages, we 
were open to including non-English language papers but none were identified in our 
searches, perhaps because locally conducted studies or articles in local languages are often 
not published in indexed journals.48 We may have missed important information from these 
studies but lacked resources to extend the search to non-indexed publications and grey 
literature. 
We followed rigorous Cochrane methodology duplicating the selection, data extraction and 
quality assessment procedures but confidence in our findings is limited by the high risk of 
bias in most of the studies included.   We only included controlled trials because we wanted 
to assess effectiveness. We acknowledge, however, that in LMICs there are many challenges 
and barriers such as lack of infrastructure, heterogeneity of resources and poor health 
literacy which discourage clinical trials.49,50 Reliable tools for measuring outcomes (e.g. 
validated questionnaires in local language, well-trained assessors, effective training facilities 
etc.) may not be available in low-resource settings reducing accuracy of assessing 
effectiveness.51,52  We did not search for health economic assessments. 
 
All our included studies reported positive outcomes, but the high risk of bias limits 
interpretation of this finding. In contrast, the evidence from studies conducted in high-
income countries are mostly at low to moderate risk of bias, so that the Cochrane review 
was able to conclude confidently that PR was an effective intervention for people with 
COPD. 23 It is likely that insufficient resources, training and facilities in LMICs is responsible 
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for the lack of high-quality trials.  This is a gap that NIHR-funded initiatives, such as 
RESPIRE,53 and RECHARGE54 aim to address.  
 
Compared to high-resource settings, under-diagnosis due to lack of awareness of CRD 
compounded by limited access to diagnostic tools such as spirometry results in a minority of 
potentially eligible participants being approached to be enrolled in studies. Poor universal 
health coverage55 and ‘catastrophic’ costs of healthcare56 further limit participation in trials. 
 
The lack of diagnostics means that patients recruited as COPD may in fact have a range of 
undifferentiated CRDs (e.g. pulmonary impairment after tuberculosis, or combined 
obstructive and restrictive disorder57). Whilst this lack of detailed characterisation may 
impact on findings, offering PR to people with CRD (regardless of specific diagnosis) may be 
a more appropriate strategy especially in resource-limited settings.      
 
There was considerable variation in the clinical status of participants which might affect 
outcomes.  There was considerable range in severity of functional limitation (see Table 1).  
In addition, some of the patients were stable at enrolment37,39,40,43,45,47 while some were 
hospitalised for a recent exacerbation.38,42,44  
 
Exercise training is the cornerstone of PR,58 and was an inclusion criterion for the studies in 
our review.   Endurance training was included in all the studies in addition to a range of 
other modalities as per recognised guidelines. Behavioural changes and continuing physical 
activities are crucial for maintaining effectiveness of PR,59 but these were not reported in 
any of the studies.  
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Education on CRD and its treatment was widely provided along with strategies on managing 
breathlessness, but other components such as self-management support, and addressing 
social care needs were rarely reported, despite evidence of effectiveness in CRDs.60 In HICs 
smoking is the predominant risk factor and cessation support is seen as essential.  Only two 
of the studies in our review reported a smoking cessation component and none reported 
avoidance of pollution and indoor biomass exposure which are also important risk factors in 
LMICs.61,62 The brief descriptions in the papers make it difficult to assess how these, and 
other important educational topics (such as inhaler technique) were addressed.   
 
Models of PR delivery depends on who, where, to whom, and how the service is delivered.63 
Different models of PR services were described in the included studies reflecting diversity in 
the healthcare context and access to PR services, individuals’ health literacy and background 
beliefs, attitudes and preferences, as well as practical factors such as availability of 
transport, and capability of payment.64 A home-based, inexpensively equipped PR service 
with minimal attendance at a potentially distant centre may be more suitable model in rural 
areas with limited resources and poor transport infrastructure.65,66 In home-based models, 
the cost to the patient is minimised, and people have flexibility in how they invest their 
time.67-69 Digital technology is a rising paradigm in LMICs, which may be considered in 
developing a remote model of PR service.70 
 
Our findings have implications for clinical practice and research.  Breathlessness is the 
principal symptom that drives the patients with CRDs to seek medical help.71 In LMICs, 
diagnosis of chronic respiratory symptoms depends on clinical history and physical 
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examination, with limited, or sometimes no, access to spirometry or other investigations.72 
Poor healthcare coverage may mean that tasks regarded as pre-requisites to referral in HICs, 
such as identifying co-morbidities, optimising pharmacotherapy and exclusion of 
contraindications, may need to be a component of PR in LMICs.73 The studies included in 
this review identified some practical solutions to these challenges, but high-quality evidence 
of the clinical and cost effectiveness of these pragmatic approaches is urgently needed. 
 
In conclusion, recommendations in PR guidelines typically reflect services delivered in high-
income settings.   Our literature review, although identifying studies with high to moderate 
risk of bias, highlighted the feasibility of conducting PR in LMICs with positive effects on 
outcomes such as exercise tolerance, HRQoL and symptoms improvement. Our findings 
point to the need for PR services that are effective across a broad range of (potentially 
poorly differentiated) CRDs, overcoming barriers of cost, distance and access to healthcare 
such that they are deliverable and sustainable in low-resource settings with minimal 
equipment.    Only then will the known benefits of PR be available to address the increasing 
burden of CRDs in LMICs.  
 
Methods 
Published review protocol 
The review is registered with PROSPERO [ID: CRD42019125326]. The detailed systematic 
review protocol is published74 with salient points described here.  We followed the 
procedures described in the Cochrane Handbook for Systematic Reviews of Interventions.75  
 
Deviation from published protocol 
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We planned to use Grading of Recommendations Assessment Development and Evaluation 
(GRADE76) approach to rate the quality of evidence for primary outcomes and the important 
secondary outcomes, however, there was substantial missing information in the papers, so 
we were unable to apply the GRADE approach. (see Supplementary results 2 for our limited 
GRADE exercise). 
 
Search strategy 
Table 4 gives details of the search strategy developed to detect randomised controlled trials 
(RCTs) and controlled clinical trials (CCTs) of ‘Pulmonary Rehabilitation’ AND ‘COPD or other 
CRD’ AND ‘LMIC or low-resource settings’ from 1990 (when global COPD guidelines first 
recommended PR77) to November 2018 with no language restrictions.  We searched 
MEDLINE (Supplementary methods 1) EMBASE, Global Health (CABI), AMED, PubMed, and 
the Cochrane Database of Controlled Trials (CENTRAL). We did not undertake hand 
searching as we found no journal that regularly published PR papers in LMICs. Additionally, 
we conducted forward citations of the included articles. We used EndNote for overall data 
management.  
The searches were completed on 28th October 2018, with a pre-publication update on 8th 
March 2020 using the ‘efficient and effective’ approach78 of forward citation using Google 
Scholar, of all included papers and the Cochrane review.23  
 
Selection process  
Details of inclusion and exclusion criteria and definitions used are in Table 4.  In summary, 
we undertook a duplicate selection process using rules for operationalising the 
inclusion/exclusion criteria (see protocol for details74).  Two trained reviewers (MH and NU) 
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independently screened titles and abstracts, then full text papers (MH, NU, and KD). 
Disagreements were resolved by discussion, involving HP and RR or the wider team as 
necessary. We reported the process in a PRISMA flow diagram (Fig. 1).79  
 
Outcome measurement 
Our primary outcomes were between-group difference in functional exercise capacity (e.g. 
6-minute walking test (6-MWT80-82), and HRQoL (e.g. St George’s Respiratory Questionnaire 
(SGRQ)83,84). We also included breathlessness (e.g modified Medical Research Council 
Dyspnoea score (mMRC)85). These are defined, and secondary outcomes described in Table 
4. 
Data extraction and risk of bias 
Two reviewers (MH and NU, and checked by HP) extracted data on a piloted data extraction 
form (Supplementary methods 2) based on the Cochrane Effective Practice and. 
Organisation of Care (EPOC) guidance,86 MH and NU (checked by HP) independently 
assessed the methodological quality of all included studies according to the Cochrane Risk 
of Bias (RoB) tool.75  
 
Data analysis 
The analysis addressed our three objectives:  
1. Effectiveness of PR in low-resource settings: On the basis of our initial scoping, we 
anticipated that our included studies would have substantial clinical, methodological 
and statistical heterogeneity, and meta-analysis would not be appropriate. We, 
therefore, conducted a narrative synthesis illustrating the key outcomes on a 
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Harvest plot.87,88 In order to ensure transparency of interpretation, the rules that 
underpinned the Harvest plot are defined in the footnote to Table 1.   
2. Components used in effective studies: We identified the components that are 
described in internationally recognised guidelines13,15,89 using categories from the 
American Thoracic Society/European Respiratory Society (ATS/ERS) task force 
report,13 British Thoracic Society guidelines for PR15 and Lung Foundation of 
Australia.90  We then constructed a matrix with the components used in the 
(effective and ineffective) studies.   
3. Models of care used in the PR interventions:  We described the models of care used, 
including PR providers and (if specified) their training, venue and equipment 
available, number and frequency of training sessions, use of telehealth and 
strategies for sustainability.  
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Table 1. Summary table of included trials with key characteristics, main findings and interpretation 
Author-year;  
Country; Intervention; 
Design; Duration; 
Risk of bias (RoB) 
Chronic Respiratory 
Condition; 
Age: Mean (SD); 
Inclusion criteria; 
Recruited/completed 
PR baseline 
assessment 
Clinical outcomes
FUNCTIONAL EXERCISE CAPACITY 
HEALTH RELATED QUALITY OF LIFE (HRQoL) 
BREATHLESSNESS 
 
Comments and conclusion for the Harvest plot
de Grass 2014  
 
South Africa; 
6w CHC to home 
PR: exercise + education; 
RCT: PR vs UC; 
FU: 6w; 
MODERATE RoB 
 
Post pulmonary TB;
Age: 18 to 65yrs; 
Ambulant patient 
contactable by 
telephone; 
Recruited: 102 (PR=51, 
UC=51);  
Analysed: 67 (PR=33, 
UC=34) 
Spirometry;
6-MWT; 
mBorg; 
EQ-5D;  
Par-Q 
FUNCTIONAL EXERCISE CAPACITY 
No between-group difference in 6-MWT (m 
(SD)): Adjusted: NS 
• PR pre: 401.2 (96.1); post: 411.0 (79.8) 
• UC pre:340.0 (104.7); post: 356.9 (78.7) 
HRQoL not assessed 
BREATHLESSNESS 
No between-group difference in mBorg mean 
(SD): Adjusted NS 
• PR pre: 10.1 (2.3); post: 10.4 (1.8) 
• UC pre: 11.4 (1.6): post: 11.24 (1.5) 
Significant difference lost when adjusted for 
large baseline differences. 
Attrition 35%: similar in both groups. 
 
FUNCTIONAL EXERCISE CAPACITY** 
Illustrated as no significant changes (no effect) 
 
BREATHLESSNESS** 
Illustrated as no significant changes (no effect) 
Duruturk 2015  
 
Turkey; 
6w Hospital OPD 
 PR: cycle-ergometry 
training or callisthenic 
exercises; 
Three groups RCT: PRCycle 
vs PRCali vs UC 
FU: 6w; 
MODERATE RoB 
Mod/Severe COPD;
Age: PRCycle=61y, 
PRCali=61y, vs UC=64y 
No cCI to PR 
Recruited: 47(PRCycle=16, 
vs PRCali=16, vs UC=15); 
Analysed: 42(PRCycle=15, 
vs PRCali=14, vs UC=13) 
Spirometry; 
Cycle 
ergometry; 
FT; 
ECG; 
mMRC 
FUNCTIONAL EXERCISE CAPACITY 
PRCycle and PRCali Between group difference** in 
6-MWT (m (SD)): p<0.001 
• PRCyclepre: 448.7 (60.9); post: 514.2 (59.3) 
• PRCalipre: 395.6 (98.2); post: 482.3 (65.4) 
• UC pre: 413.6 (125.8); post: 413.5 (121.8) 
HRQoL 
PRCycleand PRCali Between group difference in 
SGRQ (mean (SD)): p=0.001 
• PRCycle pre: 49.3 (19.6); post: 28.7 (12.9) 
• PRCali pre: 49.3 (19.6); post: 26.7 (15.9) 
• UC pre: 45.6 (15.0); post:45.4 (13.7) 
BREATHLESSNESS 
PRCycleand PRCaliBetween group difference in 
mMRC(mean (SD)): p<0.001 
• PRCycle pre: 3.3 (0.9); post: 1.8 (0.6) 
• PRCali pre: 2.9 (1.0); post: 1.8 (0.8) 
• UC pre: 2.6 (0.8); post: 2.7 (0.8) 
Three groups, small numbers but minimal 
attrition 
 
FUNCTIONAL EXERCISE CAPACITY** 
Illustrated as a significant positive effect  
 
 
HRQoL** 
Illustrated as a significant positive effect  
 
 
 
 
 
BREATHLESSNESS** 
Illustrated as a significant positive effect  
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Deepak 2014 
 
India; 
12w Hospital OPD: 
Exercise + Education; 
RCT: PR vs UC; 
FU: 12w; 
HIGH RoB 
Males recruited 2w post 
AECOPD; 
Age: PR=58.4(6.8); 
UC=59.4(6.7); 
Recruited: 60 (PR=30, 
UC=30); 
Analysed: 56 (PR=28, 
UC=28) 
Spirometry;
6-MWT; 
mMRC; 
SGRQ; 
ABG 
 
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)) 
• PR pre: 303.1 (84.5); post: 340.5 (86.2); 
p<0.001 (improved) 
• UC pre: 288.3 (96.1); post: 260.0 (100.2); 
p<0.001 (worsened) 
HRQoL 
Within group change in SGRQ (mean (SD))  
• PR pre: 53.7 (12.9); post: 39.0 (12.9); p<0.001 
(improved) 
• UC pre: 57.3 (18.5); post: 62.6 (18.7); p<0.002 
(worsened) 
BREATHLESSNESS 
Within group change in mMRC  
• PR improved; p<0.013 
• UC not improved; p<0.102 
Minimal attrition.  Between group significance 
not reported 
  
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PR 
group (worsened in UC group) 
 
HRQoL* 
Illustrated as a significant improvement in PR 
group (worsened in UC group) 
 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
group (not in UC) 
Elci 2008 
 
Turkey; 
12w Hospital OPD (+ 
Home): 
Exercise + Education; 
RCT: PR vs UC; 
FU: 4,8,12w; 
HIGH RoB 
Patient with GOLD -
defined COPD 
Age: PR=59.7(8.6); UC = 
58.1(11.5); 
Recruited: 78 (PR=39; 
UC=39); 
Analysed: NR 
Spirometry;
6-MWT; 
SGRQ; 
mMRC; 
HADS; 
SF-36 
FUNCTIONAL EXERCISE CAPACITY  
Within group change in 6-MWT (m (SD)) 
• PR pre: 312.4 (56.3); post: 328.9 (48.8); 
p=0.001 (improved) 
• UC pre: 305.1 (54.6); post: 298.2 (52.8); 
p=0.001 (worsened) 
HRQoL 
Between group difference in SGRQ (mean (SD)); 
p=0.001 
• PR pre: 60.3 (18.2); post: 45.9 (11.6)   
• UC pre: 61.7 (19.9); post: 65.5(17.4) 
BREATHLESSNESS 
Within group change in mMRC (mean (SD));  
PR pre: 3.2 (0.6); Post: 2.89 (0.7); p=0.001 
(improved) 
UC: not reported 
Attrition not reported. Between group 
significance for 6-MWT and mMRC not 
reported 
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PR 
group (worsened in UC). 
 
HRQoL** 
Illustrated as a significant positive effect  
 
 
BREATHLESSNESS* 
Insufficient information to estimate the 
change as the data of UC is not reported 
Akinci 2011 
  
Turkey; 
12w Home+Tel support: 
Clinically stable, severe 
/very severe COPD; Age: 
PR=71.8 (7.8); UC=65.1 
(10.2); 
Spirometry 
6-MWT  
SGRQ,  
BDI  
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)): 
• PR pre: 157.9 (64.5); post: 190.3 (65.0); 
p=0.001 (improved) 
Intervention group worse at baseline. Attrition 
is approx 40% in both groups.  Between group 
significance not reported  
FUNCTIONAL EXERCISE CAPACITY* 
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Exercise + Education; 
CCT: PR vs UC; 
FU: 12w; 
HIGH RoB 
Recruited: 52 (PR=27; 
UC=25);  
Analysed: 32 (PR=16; 
UC=16) 
ABG
 
• UC pre: 176.3 (54.9); post: 170.6 (55.4); p=0.16 
(NS) 
HRQoL 
Within group change in SGRQ (mean (SD)) 
• PR pre: 55 (16 ); post: 37 (13); p=0.001 
(improved)  
• UC pre:  45 (18); post: 47 (16); p=0.06 (NS) 
BREATHLESSNESS 
Within group change in BDI (mean (SD)) 
PR pre: 5.2 (1.6); post: 7.9 (1.5); p=0.001 
UC pre: 6.1 (2.1); post: 5.9 (1.5); p=0.35 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
HRQoL* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
Farias 2014 
 
Brazil; 
8w Local park: Exercise + 
Education (Hospital); 
RCT: PR vs UC; 
FU: 8w; 
HIGH RoB 
COPD patients 
Age: PR=64.6(10.1); 
UC=70.5(8.1); 
Recruited: 38 (PR-19; UC-
19); 
Analysed: 34 (PR-16; UC-
18) 
Spirometry
6-MWT; 
SGRQ; 
BODE index 
 
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)) 
• PR pre: 430.0 (80.6); post: 472.0 (72.7) p<0.05 
(improved) 
• UC pre: 383 (72.5); post: 331.8 (86.7) p=NS 
HRQoL 
Within group change in SGRQ (mean (SD)) 
• PR pre: 42.8 (SD 14.7); post: 26.4 (SD 7.3) 
p<0.05 
• UC pre: 55 (17); post: 64.3 (12) p=NS 
Text states ‘significantly different intergroup 
scores after the intervention– but no data. 
BREATHLESSNESS 
Within group change in MRC (mean (SD)) 
• PR pre: 2.3 (0.8); post: 2.0 (0.6) (P<0.05) 
(improved) 
• UC pre: 2.8 (0.9); post: 3.3 (08) NS 
PR group was younger, less symptomatic, 
better baseline 6-MWT. Minimal attrition.  
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PR 
group (UC worsened – significance NR) 
HRQoL* 
Illustrated as a significant positive effect  
 
 
 
 
 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
Paz-Diaz 2007 
 
Venezuela; 
8w Hospital OPD; 
PR:Exercise + Education; 
RCT: PR vs UC; 
FU: 8w; 
HIGH RoB 
Stable, severe COPD;
Age: PR=67 (5); 
UC=62(7); 
Recruited: 24 (PR-10; UC-
14) 
Analysed: NR 
Spirometry 
SGRQ; 
MRC;  
Beck 
Depression 
Inventory 
 
FUNCTIONAL EXERCISE CAPACITY 
not assessed 
HRQoL 
Within group change in SGRQ (mean (SD)) 
• PR pre: 58 (13); post: 45 (12); p<0.001 
• UC pre: 55 (16); post: 58 (16); p=NS 
BREATHLESSNESS 
Within group change in MRC (mean (SD)) 
Attrition is not reported.  Between group 
significance not reported 
 
HRQoL* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
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• PR pre: 2.1 (0.5); post: 1 (0.5); p<0.01 
• UC pre: 2.1 (0.6); post: 2.1 (0.5); p=NS  
group (no significant change in UC) 
Pradella 2015 
 
Brazil; 
8w (1-w Hospital then 
Home  
PR: Exercise + Education; 
RCT: PR vs UC; 
FU 8w; 
HIGH RoB 
GOLD defined COPD; 
Age: PR=62.4(10.7); 
UC=65.3(8); 
Recruited: 50 (PR=32; 
UC=18); 
 Analysed: 44 (PR=29; 
UC=15) 
Spirometry;
6-MWT; 
SGRQ 
FUNCTIONAL EXERCISE CAPACITY 
Between group difference in 6-MWT (m (SD)); 
MD 60.2 (95%CI 4.6 to 115.7) p<0.05 
• PR pre: 485.1 (79.6); post: 550.8 (100.7)  
• CG pre: 456.5(71.1); post: 462.1 (101.4)  
Between group difference in ESWT: MD 285.42 
(7.1 to 563.8) 
• PR pre: 708.4 (364.4); post: 1,025.0 (706.2) 
• UC pre: 923.7 (588.8); post: 954.9 (572.4) 
HRQoL 
Between group difference in SGRQ (mean (SD)); 
MD 9.7 (-1.0 to -0.1) p<0.05 
• PR pre: 50.3 (20.9); post: 43.6 (18.5)  
• UC pre: 49.1 (23.2); post: 52.3 (24.5)  
BREATHLESSNESS 
Between group difference in Borg scale (mean 
(SD)) NS 
PR pre: 0.24 (0.6); post: 0.13(0.4) 
UC pre: 0.26 (0.8); post: 0.33(0.7) 
Rehabilitation group had worse lung function. 
 
FUNCTIONAL EXERCISE CAPACITY** 
Illustrated as consistently a significant positive 
effect  
 
 
 
 
HRQoL** 
Illustrated as a significant positive effect  
 
 
 
BREATHLESSNESS** 
Illustrated as no significant changes (no effect) 
Karapolat 2007 
 
Turkey; 
8w Hospital OPD 
PR: Exercise + Education; 
RCT: PR vs UC; 
FU: 8w; 
HIGH RoB 
Stable mild/moderate 
COPD; 
Age: PR=65.1(9.4); 
UC=66.6(8.4); 
Recruited: 49 (PR=27; 
UC=22); 
Analysed: 45 (PR=26; 
UC=19) 
Spirometry;
6-MWT; 
SGRQ; 
ABG; 
VAS 
(Dyspnoea) 
 
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)) 
• PR pre: 261.6 (41.5); post: 383.2 (50.4); p<0.05 
(improved) 
• UC pre: 226.8 (62.7); post: 241.9 (57.4); NS 
HRQoL 
Within group change in SGRQ (mean (SD)) 
• PR pre: 45.1 (17.8); post: 28.3 (15.2) p<0.05 
(improved) 
• UC pre: 50.7 (15.7); post: 47.0 (17.3); NS 
BREATHLESSNESS 
Within group change on VAS (mm (SD)) 
PR pre: 5.9 (2.0); post: 3.1 (1.6); p<0.05) 
UC pre: 5.3(2.0); post: 5.8 (1.8); p=NS 
Five ‘ineligible’ UC participants were excluded 
after randomisation. 
 
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
HRQoL* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
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De Souto Araujo 2012 
 
Brazil; 
8w Hospital Physio centre 
PR: Exercise (Floor or 
Aquatic based) + 
Education; 
Three groups RCT: PRFl vs 
PRAq vs UC; 
FU: 8w; 
HIGH RoB 
Stable mod/severe/ very 
severe COPD; 
Clinically stable; 
Age: PRFl=56.9 (7.9); 
PRAq=62.4(9.9); 
UC=71.1(10.1); 
Recruited: 42 (PRFl=14; 
PRAq=14; UC=14); 
Analysed: 32 (PRFl=13; 
PRAq=8; UC=11) 
Spirometry;
6-MWT; 
SGRQ;  
BODE index; 
Borg Fatigue 
score 
 
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)):  
• PRFl pre: 446.5 (114.5); post: 468.8 (106.8); NS 
• PRAq pre: 434.6 (121.0); post: 490.9 (137.8); 
p=0.02 (improved) 
• UC pre: 393.3 (135.1); post:360.7 (129.4); 
p=0.02 (worsened) 
HRQoL 
Within group change in SGRQ (Data NR) 
• PRFl p=0.001 
• PRAq p=NS  
• UC p=NS  
BREATHLESSNESS 
Within group change in MRC (Data NR) 
• PRFl p=NS 
• PRAq p=<0.001 (Improved) 
• UC p=<0.05 (worsened) 
Differential attrition in already groups. Control 
group was older.  Inter-group comparison all 
NS, but no paired comparisons (PRFl/UC or 
PRAq/UC).  Some data only illustrated 
graphically. 
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PRFl 
group, not in PRAq (no significant change in UC)
HRQoL* 
Illustrated as a significant improvement in PRFl 
group, not in PRAq and UC 
 
BREATHLESSNESs* 
Illustrated as a significant improvement in PRAq 
group, not in PRFG no significant change in UC) 
Ghanem 2010 
 
Egypt; 
8w Home + Hospital 2 
weekly 
PR:Exercise + Education; 
RCT: PR vs UC; 
FU: 8w; 
HIGH RoB 
Mod /severe COPD post 
admission 
Age: PR=56.9 (11.5); 
UC=56.43 (9.03); 
Recruited: 39 (PR=25; 
UC=14); Analysed: 39 
(PR=25; UC=14) 
 
Spirometry;
6-MWT; 
CRQ-SAS 
 
FUNCTIONAL EXERCISE CAPACITY 
Significant between group difference in 6-MWT 
(m (SD)): MD 58.2 ±11.2 (p<0.001) 
• PR pre: 88.7 (19.1); post: 141.7 (23.1)  
• UC pre: 83.8 (15.9); post: 68.6 (32.1) 
HRQoL 
Between group significant difference in all CRQ 
domains (mean (SD)). 
Fatigue MD 5.3 (1.9-9.8) p=0.004 
• PR pre: 9.8 (2.8); post: 17.4 (5.4) 
• UC pre: 11.6 (6.1); post: 13.2 (5.1) 
Emotion MD 8.7 (2.5-15) p=0.008 
• PR pre: 22.1 (5.8); post: 33.5 (7.2) 
• UC pre: 27.0 (12.6); post: 29.7 (11.4) 
BREATHLESSNESS MD 5.5 (3.0-9.0) p=0.003 
• PR pre: 11.8 (5.0); post: 19.6 (5.2) 
• UC pre: 12.4 (4.4); post: 13.5 (4.3) 
Unclear why uneven numbers in the groups
 
FUNCTIONAL EXERCISE CAPACITY** 
Illustrated as a significant positive effect 
 
 
 
HRQoL** 
Illustrated as a significant positive effect 
 
 
 
 
 
BREATHLESSNESS** 
Illustrated as a significant positive effect 
Mohammadi 2013 
 
Mod/severe COPD; 
Age: NR (though stated 
ADL level; 
SF-12 QOL; 
FUNCTIONAL EXERCISE CAPACITY 
Not measured 
Sample size calculation: 20/group, and 
20/group were analysed.  No data on number 
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Iran; 
8w (1-w in Hospital pre-
discharged then Home) 
PR:Exercise + Education; 
RCT: PR vs UC; 
FU: 8w; 
HIGH RoB 
to be similar between 
groups;  
Recruited: 40 (PR=20; 
UC=20);  
Analysed: NR 
 
FSS HRQoL
Significant between group difference in SF-12 
(mean (SD)); p<0.001 
• PR pre: -21.3 (11.5) post: -14.5 (7.1);  
• UC pre: –24.6 (9.2); post: –27.1 (8.5);  
BREATHLESSNESS 
Not measured 
recruited/ attrition.
 
HRQoL** 
Illustrated as a significant positive effect 
 
 
 
 
 
 
Singh 2003 
 
India; 
4w Hospital then Home 
PR: Exercise + Education; 
RCT: PR vs UC; 
FU: 4w; 
HIGH RoB 
 
Stable, severe COPD;
Age: 59.3 (6.4); 
Recruited: 40 (PR=20; 
UC=20); 
Analysed: NR 
Spirometry;
6-MWT;  
CRQ 
 
FUNCTIONAL EXERCISE CAPACITY 
Within group change in 6-MWT (m (SD)) 
• PR pre: 261 (113); post: 315 (118); p< 0.001 
(improvement) 
• UC pre: 257.7 (158); post: 264 (157); NS 
HRQoL 
a group difference in CRQ (mean (SD)); p<0.001 
•PR pre: 2.9 (0.9); post: 3.8 (0.9) P<0.001 
•UC pre: 3.1(0.8); post: 3.2 (0.8) NS 
BREATHLESSNESS 
Within group change in dyspnoea domain of CRQ 
(mean (SD)) 
• PR pre: 3.16 (1.0); post: 4.1 (0.9); p<0.001  
• UC pre: 3.5 (0.8; post: 3.6(0.8); S 
Baseline characteristics not given but reported 
as not significantly different. Attrition not 
reported 
FUNCTIONAL EXERCISE CAPACITY* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
HRQoL* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
BREATHLESSNESS* 
Illustrated as a significant improvement in PR 
group (no significant change in UC) 
 
* Hatched in the harvest plot to show within group comparison. 
** Solid in the harvest plot to show between the group comparison. 
Abbreviations:   IG- Intervention Group, CCT- Controlled Clinical Trial, CG- Control Group, EG- Experimental Group,  RG- Rehabilitation Group, GPR- Pulmonary Rehabilitation 
Group, HBRG- Home-Based Rehabilitation Group, FG- Floor Group, AQ- Aquatic Group, UCG- Usual Care Group, 6-MWT- 6-Minute Walk Test, EQ-5D- EuroQual 
questionnaire, Par-Q-  Physical Activity Readiness Questionnaire, RoB- Risk of Bias, HRQoL- Health Related Quality of Life, SGRQ- Saint George Respiratory Questionnaire, 
cycle ergo- Cycle Ergometry, FT- Fitness Test, PEPR- post-exacerbation pulmonary rehabilitation, CTWPR- conventional treatment without pulmonary rehabilitation, SF-36- 
Short Form-36, HADS- Hospital Anxiety and Depression Scale,  BDI- Baseline Dyspnoea Index, ABG- Arterial Blood Gas, m- metres, MD- Mean Difference, MIP- Maximum 
Inspiratory Pressure, MEP- Maximum Expiratory Pressure, VAS- Visual Analogue Scale, NS- Not Significant. 
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Table 2.  Components of pulmonary rehabilitation from the selected papers 
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Exercise programme
Endurance training (including interval 
training) 
             13
Resistance/Strength training              7 
Upper Limb exercise              6 
Flexibility training              4 
Breathing exercises (including IMT)              8 
Other components 
Pursed-lip breathing              9 
Diaphragmatic breathing              7 
Knowledge (disease/medication)           10
Skill acquisition (airway clearance, inhaler 
technique, use of oxygen)  
       7
Psychological interventions (CBT, relaxation)              4 
Coping strategies (Pacing, energy 
conservation) 
             5 
Nutrition               4 
Physical activity (Unsupervised exercise)    3
Smoking cessation    2
Self-management    1
Social support (including walking aids)   1
Pharmacological optimisation    2
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Table 3. Models of pulmonary rehabilitation services 
 
Study Who Where Whom How What (components of PR are 
described in table 2) 
de Grass 2014 
 
Assessor: 
Physiotherapist  
Provider: Physiotherapist  
 
Assessment (0, 3, 6 weeks): 
Community health centre  
PR: Initial training: Community 
health centre, then Home 
Post-TB patients after 
active treatment 
• PR course: 6 weeks 
• Frequency: Daily 
• Duration of sessions: NR 
Home exercise,  
Physiotherapy/breathing exercises,  
Education materials 
Duruturk 
2015 
Assessor: 
Physiotherapist 
Provider:  
Physiotherapist 
 
Assessment (0, 6 weeks): Hospital 
PR: Hospital  
Moderate/severe 
stable COPD patients 
• PR course: 6 weeks 
• Frequency: 3 times a week 
• Duration of sessions: ≈30 mins 
Exercise training  
Physiotherapy/breathing exercises,  
Education session  
Deepak 2014 
 
Assessor: NR 
Providers:  
Physiotherapist, Doctor 
Assessment (0, 12 weeks) Hospital 
PR: Hospital 
COPD patients 2-
weeks after hospital 
discharge 
• PR course: 12 weeks 
• Frequency: NR 
• Duration of session: 2 hours 
Exercise training 
Physiotherapy/breathing exercises 
Education sessions 
Psycho-social support 
Elci 2008 
 
Assessor: Nurse  
Providers:  
Physiotherapist, Doctor 
Assessment (0, 4, 8, 12 weeks): 
Hospital  
PRP: Hospital (+ home exercises) 
Stable COPD patients • PR course: 12 weeks 
• Frequency: 2 times a week 
• Duration of sessions: 90 ≈mins 
 
Exercise training 
Physiotherapy/breathing exercises 
Education sessions + materials  
Akinci 2011 
 
Assessor: Doctor 
Provider:  Nurse trained 
in PR. 
Assessment (0,12 weeks): 
Hospital  
PR: Home + telephone support 
COPD patients 
 
• PR course: 12 weeks 
• Frequency: Daily exercise 
• Duration of home visits: 90 mins  
Exercise training, + home exercise 
Physiotherapy/breathing exercises 
education sessions 
 
Farias 2014 
 
Assessor: 
Physiotherapist 
Provider:  
Physiotherapist 
Assessment: (0, 8 weeks); Hospital
PR: Supervised in local park 
(education at Hospital)  
COPD patients • PR course: 8 weeks 
• Frequency: Five times a week 
• Duration of exercise sessions: 40 
 60 mins 
Exercise: walking in local park 
Physiotherapy/breathing exercises 
Education sessions  
Paz-Diaz 2007 
 
Assessor: NR 
Provider:  NR 
Assessment (0, 8 weeks): Hospital 
PR: Hospital  
Stable, severe COPD  • PR course: 8 weeks 
• Frequency: 3 times per week 
Exercise training 
Physiotherapy/breathing exercises 
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• Duration of PR: 60 mins 
Pradella 2015 
 
Assessor: NR  
Provider:  NR 
Assessment: (0, 8 weeks): 
Rehabilitation Centre  
PR: 1-week Rehabilitation Centre, 
then home + telephone support 
COPD patients • PR course: 8 weeks 
• Frequency: 3 times a week 
• Duration of sessions: 90 mins 
Exercise (walking and stairs),  
Physiotherapy/breathing exercises 
Printed material 
 
Karapolat 
2007 
 
Assessor: Doctor 
Provider:  
Physiotherapist 
Assessment (0, 8, 12 week): 
Hospital 
PR: Hospital 
Mild, moderate, and 
severe stable COPD 
• PR course: 8 weeks 
• Frequency: 3 times a week 
• Duration of sessions: 90 mins 
Exercise,  
Physiotherapy/breathing exercises 
Education 
De Souto 
Araujo 2012 
Assessor: NR 
Provider:  NR 
Assessment: (0, 8 weeks) 
Physiotherapy Centre 
PR:  Physiotherapy Centre 
Moderate, severe, and 
very severe stable 
COPD; 
• PR course: 8 weeks  
• Frequency: 3 times a week 
• Duration of PR sessions: 90 mins 
Exercise (floor or pool) 
Optimisation of pharmacotherapy 
Ghanem 2010  
 
Assessor: Doctor, nurses 
Provider:  Pulmonary 
specialist, nurses 
Assessment: (0, 8 weeks); In 
hospital pre-discharge 
PR: Home + hospital 2 weekly 
Post-exacerbation 
COPD patients 
• PR course: 8 weeks 
• Frequency: Every other day 
• Duration of sessions: NR 
Exercise,  
Physiotherapy/breathing exercises 
Education 
Mohammadi 
2013 
 
Assessor: Nurse 
specialist 
Provider:  Nurse at home 
Assessment: (0, 8 weeks) 
PR: 1-week in hospital pre-
discharge then home + telephone 
alternate days 
Post-exacerbation 
COPD patients 
• PR course: 8 weeks 
• Frequency: Alternate days; 
• Duration of PR sessions: NR 
Exercise,  
Physiotherapy/breathing exercises 
Education (3 1-hour sessions) 
Singh 2003 
 
Assessor: NR 
Provider:  NR 
Assessment: (0, 4 weeks) Hospital 
PR: Hospital then home + weekly 
supervision 
Stable, severe COPD • PR course: 4 weeks 
• Frequency: Twice a day 
• Duration of PR sessions: 30 mins 
Exercise,  
Physiotherapy/breathing exercises 
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Table 4. PICOS search strategy 
 
PICOS Description, inclusion/exclusion criteria Operational rules 
Population Adults with CRDs. Comorbidity was 
not an exclusion criterion 
No age restrictions 
Any CRD (COPD, post TB, remodelled asthma, bronchiectasis, 
interstitial lung disease) or poorly differentiated respiratory 
conditions that cause chronic symptoms.  We excluded 
studies that included non-respiratory causes for symptoms.  
Intervention Pulmonary Rehabilitation (PR) 
which comprised both exercise 
AND at least one non-exercise 
component 
Non-exercise components included recognised PR 
interventions such as patient education, breathing exercises, 
energy conservation training, self-management skill 
development.  
We included optimisation of pharmacotherapy as a 
component because in low resource settings this may not be 
accessed/provided elsewhere. 
Comparison Population who are not given PR Individuals received usual care as normal in the setting  
Outcomes  Primary outcomes: 
• Functional exercise capacity  
• Health-Related Quality of Life 
(HRQoL) 
Secondary outcomes: 
• Symptom control 
• Psychological status  
• Uptake of the service, 
completion rates 
• Adverse effects  
Validated instruments considered: 
Functional exercise capacity: 6-Minute Walk Test, Endurance 
Shuttle Walking Test  
HRQoL: SGRQ, CRQ, SF-36, SF-12, EQ-5D  
Symptom control: mMRC, Borg scale 
Psychological status: HADS, PHQ-9, STAI, Beck Inventory test 
Non-validated instruments were extracted, but evidence 
noted as being less reliable 
Setting Low-resource settings  
Typically characterised by a lack of 
funds leading to: 
• Limited access to medication, 
equipment 
• Poorly developed infrastructure 
• Few trained personnel 
• Limited access to routine care  
In practice, this decision was normally based on the World 
Bank category of a LMIC country at the time of the study.  
However, whilst low resource settings were usually in LMICs, 
PR delivered in a well-resourced context (e.g. a tertiary care 
hospital) in an LMIC would be excluded, and interventions in 
HICs might be included if the context was low resource (e.g. 
remote, deprived community)  
Study designs Randomised controlled trials 
(RCTs); Clinical controlled trials 
We excluded studies that did not have a control group  
Abbreviations: SGRQ: St Georges Respiratory Questionnaire; CRQ: Chronic Respiratory Questionnaire, SF-36: 
Short Form-36; SF-12: Short Form-12; EQ-5D: EuroQol Five Dimension; mMRC: Modified Medical Research 
Council; HADS: Hospital Anxiety and Depression Scale; PHQ-9: Patient Health Questionnaire-9; STAI: State-Trait 
Anxiety Inventory 
 
